AirStrip receives FDA-approval for web app

September 26, 2016
This app has just been FDA-approved. The company AirStrip, which makes a suite of mobile monitoring apps, also recently received a patent for one of its functionalities within AirStrip ONE, an ECG waveform interpretation that acts as visual calipers for clinicians to make measurements on digital waveforms. Previously, the company already received approval for the AirStrip Remote Patient Monitoring Solution, and their AirStripOB was one of the very first FDA-cleared medical apps in the AppStore.

Time saving

“This is the first step toward enabling web-based support of key AirStrip ONE functions to support a seamless user experience on all form factors, including laptops and desktops,” AirStrip Chief Development Officer JF Lancelot said in a statement. “The AirStrip One client is capable of displaying patient waveforms in near-real time as well as alarms generated by bedside monitors.”

“Time spent on documentation can be reduced and more precise information about the patient can be made available more quickly in the EMR,” Lancelot stated. “In addition, clinicians can reduce the time spent on non-clinical tasks such as finding, scanning, clipping and transporting paperwork.”

“The visual calipers and snippets functions promise to have a substantial impact not only on tele-ICU and tele-CV services, but also on clinical workflows for alarm management,” Lancelot said.


The collected information can be merged into a single document to document more complex events that can then be exported into the EMR. If the reading doesn’t turn up critical information, healthcare professionals also have the option to use the visual calipers to perform measurements without sending any unneeded information to an EMR. During a complex cardiac event, clinicians can quickly select relevant visual snippets to facilitate faster, more informed care decisions.